Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Positive inotropic agents. Generalities and classification].

A Vahanian, J Le Potier, J Sergent

    Annales De Medecine Interne
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiac CT-scan for mitral valve calcification assessment before percutaneous commissurotomy: the multicentre prospective CALCIMIT study.

    European heart journal. Cardiovascular Imaging·2026
    Same author

    Predictors of mitral annulus enlargement? A real-time three-dimensional transesophageal study.

    International journal of cardiology·2018
    Same author

    Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries.

    Journal of European CME·2018
    Same author

    Eclipsed mitral regurgitation: an unusual cause of acute heart failure.

    European heart journal. Cardiovascular Imaging·2016
    Same author

    Mitral regurgitation. Timing of surgery or interventional treatment.

    Herz·2015
    Same author

    Percutaneous aortic valve interventions in heart failure patients.

    Minerva cardioangiologica·2015

    Inotropic therapy aims to strengthen heart contractions. While digitalis and dobutamine are common, newer agents show promise but require further study for long-term safety and efficacy.

    Area of Science:

    • Cardiology
    • Pharmacology

    Context:

    • Inotropic therapy is crucial for managing heart failure by enhancing myocardial contractility.
    • Existing treatments like digitalis have limitations, including weak effects and low therapeutic index.

    Purpose:

    • To review current and emerging inotropic agents for improving myocardial contractility.
    • To evaluate the efficacy, limitations, and side-effect profiles of various inotropic drugs.

    Summary:

    • Digitalis and dobutamine are established inotropic agents, with dobutamine offering better cardioselectivity and lower myocardial oxygen consumption.
    • Newer agents include sympathomimetics (e.g., pirbuterol, prenalterol) with short-term efficacy but potential tolerance, and phosphodiesterase inhibitors (e.g., MDL 17043, MDL 19025) showing medium-term effectiveness.
    • Amrinone and its derivative milrinone are potent positive inotropic drugs, though amrinone's side effects are a concern; milrinone appears less toxic.

    Related Experiment Videos

    Impact:

    • Current inotropic drugs have limitations in efficacy and safety, highlighting the need for better treatments.
    • Emerging inotropic agents show short-term benefits, but their long-term efficacy and safety profiles require extensive investigation.
    • The development of an ideal inotropic agent with optimal efficacy and minimal side effects remains an ongoing challenge in cardiovascular medicine.